Axl is a receptor tyrosine kinase (RTK) upregulated in various tumors including cutaneous squamous cell carcinoma (SCC). Axl expression correlates with poor prognosis and induction of epithelial-mesenchymal transition (EMT), hence we hypothesized that Axl is involved in the disruption of cell-cell adhesion to allow invasion and chemotherapy resistance of the cancer stem cell population. Cutaneous SCC cell lines with stable knockdown of Axl were generated using retroviral vectors. Axl depletion altered expression of intercellular junction molecules increasing cell-cell adhesion with downregulation of Wnt and TGFbR signaling. Furthermore, Axl expression correlated with the expression of putative cancer stem cell markers, CD44 and ALDH1, increased resistance to chemotherapy drugs, enhanced sphere formation ability and expression of EMT features by cancer stem cells. Axl depletion resulted in loss of tumor formation in an in vivo zebrafish xenograft model. In conclusion, these data suggest that abrogation of Axl results in loss of cancer stem cell properties indicating a role for Axl as a therapeutic target in chemotherapyresistant cancer.
INTRODUCTION
Cutaneous squamous cell carcinoma (SCC) is the most aggressive non-melanoma skin cancer. Axl, a member of the TAM family of RTKs, 1 is expressed in cutaneous SCC 2 and promotes SCC survival. 3 In tumors, Axl is frequently found in a constitutively active state, due to autocrine action of its ligand, Gas6. 4, 5 Axl upregulation leads to cancer cell metastasis, [6] [7] [8] [9] whereas Axl suppression results in decreased invasion of breast cancer cells. 10 Axl expression can be induced by EMT transcription factors such as Snail, Twist, Zeb2 or Slug. 11 In addition, Slug-or H-Ras-induced EMT leading to upregulation of vimentin was associated with increased expression of Axl. 12 Loss of intercellular adhesion is crucial for invasion and metastasis. 13 Adhesion between epithelial cells is mediated by adherens junctions, desmosomes and tight junctions (TJs). 14 E-cadherin is the main adherens junction component and a key determinant of tumor progression. 15 Cadherin-cadherin adhesive binding is supported by intracellular interactions with a-, b-and p120-catenin, whereas linking to the actin cytoskeleton is mediated via a-catenin or indirectly through actin-binding proteins. 16 Interestingly, b-catenin is also a mediator of Wnt signaling, an embryonic pathway that regulates stemness. 17 In the presence of the Wnt ligand, inhibition of GSK3 by phosphorylation leads to stabilization of cytoplasmic b-catenin and translocation to the nucleus to regulate gene transcription. 18, 19 Desmosomes anchor stress-bearing intermediate filaments and mediate strong cell-cell adhesion. 20 TJs are crucial for epidermal adhesion and are composed of transmembrane molecules (occludin (OCLDN), claudin (CLDN) and junctional adhesion molecules (JAM)) linked to the actin cytoskeleton through peripheral membrane proteins such as zonula occludens (ZO). 21 Critical events during EMT include downregulation of E-cadherin, induction of vimentin, matrix metalloproteinases and growth factor receptor expression. 22 In addition, activation of EMT by TGFb promotes the generation of cells with stem cell-like features. 23 Cancer stem cells (CSCs) are more resistant to chemotherapeutic agents than the non-stem cell population 24 and studies indicating that Axl upregulation confers poor prognosis with tumor resistance to therapy 25, 26 allowed us to hypothesize that Axl signaling might influence cell-cell adhesion and stem cell characteristics of CSCs. The data demonstrate that Axl depletion has a major effect on cell junction formation, the Wnt signaling pathway and CSC properties important for SCC tumor initiation and survival.
RESULTS AND DISCUSSION
Two different short hairpin RNA (shRNA) constructs, 1053 and 2833, targeting Axl and a scrambled (Scr) control in a pSuperior retroviral delivery system were used to achieve stable knockdown (KD) of Axl in cutaneous SCC cell lines including MET1, RDEB SCC and SCC IC1. 3 Western blotting (WB) revealed that the 2833 shRNA gave the highest KD efficiency (B90% in all cell lines), compared with 1053 shRNA giving 50-60% Axl KD in MET1 and RDEB SCC ( Figure 1a and Supplementary Figure 1) . Unaltered levels of Gas6 in cells with and without Axl indicated that autocrine signaling was unaffected by Axl KD (Supplementary Figure 2) .
Interestingly, Axl-overexpressing cell lines, MET1 and RDEB SCC Scr control cells had an irregular, spindle-like appearance, whereas Axl KD cells formed tighter colonies and showed a cobblestone, densely packed morphology with prominent cell-cell borders and smaller cell area (Figure 1b) . Furthermore, the RDEB SCC cells exhibited stronger intercellular adhesion (Figure 1c , lower panel) than MET1 cells (Figure 1c , upper panel) and cell-cell attachment was increased upon Axl KD for both cell lines by over 50%.
As Axl KD affected cell-cell adhesion, additional experiments were performed to investigate the junctional proteins involved. WB demonstrated that there was no change in the expression of total Plakoglobin (PG) (Figure 1d) , desmosomal cadherin or plakophilin levels (Supplementary Figure 3) , whereas there was B40% decrease in desmoplakin I (upper band) in the cytoskeletal fraction of both 1053 and 2833 Axl KD cell lines, whereas desmoplakin II did not change significantly. A parallel experiment using small interfering RNA targeting Axl demonstrated similar findings.
In order to see whether lack of Axl affects TJ adhesion, CLDN-1 and ZO-1 expression levels were analyzed by WB in the various SCC cell lines (Figure 1e ). Axl KD caused over twofold upregulation 49 RDEB SCC and SCC IC1 50 were cultured at 37 1C with 5% CO 2 as described previously. 50 Normal HaCaT keratinocytes 51 and Phoenix packaging cells (Orbigen, San Diego, CA, USA) were grown in Dulbecco's Modified Eagle's Medium (PAA, Somerset, UK) supplemented with 10% fetal bovine serum and 1% L-glutamine (both from Sigma-Aldrich, Gillingham, UK). Custom-made shRNAs targeting Axl in gene sequence positions 1053 and 2833 were subcloned into pSuperior.retro.puro vector (pSuperior; OligoEngine Inc., WA, USA) as described previously.
3 A non-targeting scrambled 2833 shRNA (5 0 -GCGCGATATATAGAATACG-3 0 ) subcloned into pSuperior vector was used as an experimental control. Retroviral particles were generated and used to infect SCC cells as described. 3 Cell area and relative cell number were quantified using Image J. (c) Dispase was used to remove a sheet of confluent MET1 or RDEB SCC cells that were then subjected to mechanical stress. The number of fragments was counted using a dissecting microscope. Data are representative of results from three independent experiments carried out in triplicate, values represent mean±s.d. (n ¼ 3), P-values were calculated using the two-tailed t-test and *indicates Po0.05 (P ¼ 0.0224 and 0.0195, respectively). (d) Transient KD of Axl was performed using Dharmacon Smartpool small interfering RNA to Axl (siAxl) or a non-targeting control (SiC) (see Supplementary Methods). Cells were routinely lysed in Triton lysis buffer containing a complete protease inhibitor cocktail (CPIC) (Roche Diagnostics, Burgess Hill, UK) as described previously. 49 Total protein concentration was determined using a colorimetric BioRad DC Protein Assay (BioRad, Hemel Hempstead, UK). Sequential detergent extraction was performed as described by Palka et al., 52 on confluent cells grown in 60 mm dishes with modifications to isolate the cytoplasmic and cytoskeletal fractions of RDEB SCC cells (Scr and 2833). WB was performed with antibodies to Axl, desmoplakin (DP) (recognizing DPI and DPII) and PG. GAPDH and keratin 6 (K6) were used as loading controls. (e) WB analysis of ZO-1 and CLDN-1 in MET1, RDEB SCC and SCC IC1 cell lines (Scr and 2833 or SiC and SiAxl). Protein expression was normalized to GAPDH or vinculin and quantification is shown above the blots. (f ) WB was performed for E-cadherin and a-catenin expression in MET1 and RDEB SCC cell lines (Scr and 2833 or SiC and SiAxl)), then normalized to GAPDH or vinculin (quantification above the blots).
of ZO-1 expression in MET1 cells with 30% upregulation in the RDEB SCC cell line, whereas CLDN-1 levels were reduced in Axl KD cells (MET1-5% of control, SCC IC1-48% of control). These findings were replicated using small interfering RNA targeting Axl.
One of the hallmarks of EMT is loss of E-cadherin, a component of adherens junctions. Axl depletion in both MET1 and RDEB SCC cell lines resulted in upregulation of E-cadherin ( Figure 1e ) and downregulation of p120-catenin ( Figure 1e ) and a-catenin (Supplementary Figure 4) . There was, however no change in the total levels of vinculin (Supplementary Figure 4) .
Immunofluorescence staining of monolayer cultures demonstrated increased membranous localization of PG, p120-catenin and a-catenin in Axl KD cells compared with Scr control consistent with the increased cell-cell adhesion observed in Axl KD cells (Figure 2a Table 1 . Since the b-catenin/Wnt signaling is involved in EMT, we confirmed by quantitative PCR that Axl KD in MET1 cells led to the downregulation of EMT markers such as CTGF, TWIST and VIM (90% (P ¼ 0.002), 62% (P ¼ 0.0106) and 68% (P ¼ 0.0003) decrease in 2833 cells compared with Scr controls, respectively) with subsequent almost threefold (P ¼ 0.0002) upregulation of CDH-1 (E-cadherin) (Figure 2f ). In addition, we found that compared with Scr controls, MET1 2833 cells had reduced expression of TGFBR1 (by 34%, P ¼ 0.0025) and TGFBR2 (by 42%, P ¼ 0.0001), both known to regulate stemness and EMT.
Flow cytometry analysis was performed of the putative cancer stem cell marker CD44 in MET1 cells with (Scr) and without Axl (2833). Data demonstrated the existence of a distinct CD44-high population in Scr cells that was absent in cells lacking Axl (Figure 3a) . Additional sorting of MET1 Scr cells with regards to their CD44 expression (low, medium and high) and subsequent WB analysis of Axl content in these fractions proved that the expression of CD44 correlated with Axl expression (Figure 3b ). In addition, Illumina gene array data showed a correlation of Axl expression with another putative cancer stem cell marker ALDH1, 27 as indicated by almost fourfold downregulation of ALDH1 gene expression in Axl KD cells (Supplementary Information and  Supplementary Table 1) .
To study the role of Axl in the cancer stem cell population, we performed immunofluorescence staining of MET1/SCC IC1 Scr/ 2833 cell lines sorted according to their high and low CD44 expression. Both MET1 and SCC IC1 CD44-high cells overexpressing Axl (Scr) had downregulation of E-cadherin with simultaneous upregulation of vimentin, whereas Axl KD cells showed the opposite effect (Figure 3c ). There were however, no major changes in the CD44-low non-cancer stem cell population between the two cell lines characterized by their differential expression of Axl (Figure 3d ). Biddle et al. 28 detected Axl mRNA expression, along with other EMT markers, in the CD44-high/ESAlow motile cancer stem cell population. Triple staining of MET1 cells and subsequent flow cytometry analysis of Axl, CD44 and ESA was performed to identify this subpopulation (Supplementary Figure 5) . Cultured CD44-high/ESA-low cells showed a more spindly morphology, indicating a motile phenotype compared with CD44-high/ESA-high and CD44-low/ESA-low populations. In contrast, MET1 2833 cells had a cobblestoned appearance with tight colonies, indicating a more adhesive phenotype. The ability of single stem cells to grow in suspension as spheres 29 was assessed by examination of sphere formation in methylcellulose. Representative pictures of MET1 tumor spheres are shown (Figure 4a) . The unsorted MET1 Scr cells overexpressing Axl had 55% greater sphere formation ability than the 2833 cells (Figure 4b ). This ability was also increased in the MET1 Scr CD44-high population compared to other non-stem cell populations or the 2833 CD44-high fraction (Figure 4c) , which, as shown earlier (Figure 3a) , had lower expression levels of CD44 than its Scr counterpart.
Multidrug resistance of cancer cells is a major obstacle to effective chemotherapy treatment. The effect of Axl expression on survival of the total population of MET1 or SCC IC1 Scr/2833 cells was tested with etoposide and doxorubicin. Annexin V/4',6-diamidino-2-phenylindole flow cytometry indicated that the presence of Axl inhibited drug-induced cell death by almost two-or three-fold for SCCIC1 Scr and MET1 Scr cells, respectively, compared with cells with Axl KD (Figure 4d ). When individual populations were analyzed, the MET1 CD44-low non-cancer stem cell-like population of both Scr and 2833 cells (expressing low levels of Axl) showed a greater proportion of apoptotic or dead cells compared with the Scr CD44-high fraction corresponding to putative cancer stem cells (characterized by high levels of Axl expression) (Figure 4e) .
We used an in vivo zebrafish xenograft model where SCC cells are microinjected into the yolk sac of 1-day-old embryos and tumor formation is observed in adjacent epidermis after 6-8 days (Figure 4f) . At day 7, tumors (visible microscopic protrusions of the epithelium overlying the yolk sac 450 mm in diameter, containing at least 10 cells) were only observed in the skin of embryos injected with SCC IC1 Scr cells (9 of 16) compared with SCC IC1 2833 (0 of 15), P ¼ 0.0008, two-tailed Fisher's exact test. Representative bright field and immunofluorescence pictures of three tumors are presented.
All data are based on three experimental repeats unless otherwise stated and represent the mean±s.d.
Cell-cell adhesion has a crucial role in the suppression of tumor invasion. 13 In this paper, we report that depletion of the RTK, Axl, leads to therapeutically desirable changes in intercellular junctions resulting in enhanced strength of cell-cell adhesion. Axl-overexpressing SCC cells, similar to invasive tumor cells, have nuclear b-catenin staining 30 that was abrogated with Axl KD confirming a role for Axl in Wnt signaling. In addition, membranous localization of p120-catenin was observed with loss of Axl. p120-catenin can also be phosphorylated and then released from E-cadherin, allowing its translocation to the nucleus in response to a Wnt signal.
31 a-catenin binds to an already formed E-cadherin-bcatenin complex at the plasma membrane, detaching during the disassembly of adherens junctions. 32 Interestingly, cytoplasmic a-catenin switches to the membrane upon Axl KD, indicating the possibility of de novo formation of adherens junctions. It has been reported that suppression of desmoplakin can lead to nuclear translocation of PG that can be a negative regulator of the Wnt pathway. 33 Therefore, changes in nuclear activity of PG cannot be excluded and could partially explain the downregulation of nuclear b-catenin.
Analogous to our results, ZO-1 is known to localize at the cell membrane of non-invasive breast cancer cells, whereas its delocalization and diffuse cytoplasmic distribution correlates . Quantification is indicated below the blots normalized to GAPDH. (d) Nuclear and cytoplasmic extracts were prepared as described in the Supplementary Methods and WB was performed for b-catenin. Lamin A and GAPDH were used as nuclear and cytoplasmic loading controls, respectively. Quantification of b-catenin expression normalized to loading controls is shown below the blot. (e) The b-catenin-TCF luciferase reporter assay was performed (n ¼ 3 experiments) as described in the Supplementary Information. Briefly, MET1 or RDEB SCC cells (50% confluent) were co-transfected with one of the TCF reporter plasmids and pRL-TK (internal control) using FuGENE6 Transfection Reagent (Roche, Burgess Hill, UK). Twenty-four hours post transfection, transcriptional activity of b-catenin was determined using a Dual-Luciferase Reporter Assay System (Promega, Southampton, UK) to measure pTOPFlash (wt) luciferase activity. pFOPFlash, containing the same number (three copies) of mutated TCF-binding sites, was used as a negative control to which results were normalized. ** or *** indicates Po0.01 or Po0.001, respectively. (f) Quantitative PCR (qPCR) of various EMT markers was performed in MET1 cells (Scr and 2833). Total RNA was extracted using the Qiagen RNeasy Plus Mini Kit. Reverse transcription to complementary DNA was conducted using a SuperScript III First-Strand Synthesis SuperMix for qRT-PCR (Invitrogen, Paisley, UK). qPCR was carried out with the 7500 Real-Time PCR system with 7500 System Detection Software v1.4 (Applied Biosystems, Paisley, UK) using SYBR Green PCR Master Mix (Applied Biosystems) and self-designed primer sets purchased from Sigma-Aldrich. GAPDH was employed as an endogenous control. For qPCR conditions and primer sequences see Supplementary Information, Supplementary Table 2 and Supplementary Table 3 , respectively. Data are representative of results from three independent experiments carried out in triplicate, values represent mean±s.d. (n ¼ 3), P-values were calculated using two-tailed t-test and *, ** or *** indicates Po0.05, Po0.01 or Po0.001, respectively.
with the invasive phenotype. 34 Another TJ component CLDN-1 is involved in the b-catenin-TCF signaling pathway and downregulation of CLDN-1 by Axl KD emphasizes the role for Axl in this invasion-and stemness-related pathway. 35 In addition, upregulation of CLDN-1 was associated with significant disorganization of TJs in colorectal cancer indicating that its reduced expression (also found in Axl KD cells) might be a desirable effect of chemotherapy. 36 The disassembly of adherens junctions involving downregulation of E-cadherin is a prerequisite of cell conversion from the epithelial to the mesenchymal state, 37 and we found that Axl KD leads to increased expression of E-cadherin by SCC cells. Blocking Axl with small-molecule inhibitors could represent a valuable mechanism of suppression of invasive tumor behavior via reassembly of junctional molecules at the plasma membrane.
Stemness and EMT are implicated in cancer resistance to treatment. 38 Successful therapies must eliminate cancer completely and indefinitely, and tumor recurrence can be linked to persistence of a small number of chemotherapy-resistant tumor-initiating cancer stem cells. 39 Increased expression of Axl has been associated with multiple aspects of cancer progression, possibly due to its proinvasive and pro-survival role. 40, 41 A recent paper 42 demonstrated that overexpression of Axl increases breast epithelial cell expression of stemness markers and EMT. Inhibition of Axl decreased tumor formation and NFkappaB signaling. Here we demonstrate that Axl KD in cutaneous SCCs results in inhibition of Wnt signaling and the TGFb pathway, both of which are involved in EMT, migration and stemness of cancer cells. 24 Interestingly, a recent study identified the TGFb pathway as a master regulator of Axl expression during epidermal inflammation. 43 In addition, Axl-overexpressing cells 53 SCC IC1 cells (Scr or 2833) in suspension were stained with 10 mM CMTMR (Invitrogen) for 10 min in serum-free media at 37 1C, protected from light, washed twice in PBS and resuspended in PBS before injection of B40 cells into the yolk sac of 24-h-old transgenic fli1:EGFP (enhanced green fluorescent protein) embryos. Injections were performed using a pressure microinjector (Picospritzer III, Parker, OH, USA). Zebrafish embryos were dechorionated and anesthetized with 0.003% tricaine (Sigma-Aldrich) before injection. After injection, embryos were transferred to fish water (0.3 g/l marine salt) containing 0.3 g/l PTU (1-Phenyl-2-thiourea) to prevent pigment formation and were incubated at 35 1C for 6-8 days. Embryos were examined for tumor formation and imaged using a Zeiss LSM 510 confocal microscope (Zeiss, Cambridge, UK). Representative images of three tumors are shown acquired by confocal microscopy, bright field images in the upper panel, fluorescent images in the lower panel. Scale bars represent 20 mm (left column) or 50 mm (middle and right column).
exhibited better sphere formation efficiency than cells with Axl KD. The CD44-high cells form more spheres than CD44-low cells 44 and the data shown here suggest that Axl expression has an important role in this process. Axl expression was also required for in vivo tumor formation, a process most likely involving tumor-initiating CSCs. 27 In addition, CD44-high SCC cells (expressing high levels of Axl) showed typical mesenchymal features, whereas the opposite phenotype was found in cells with Axl KD.
Data presented in this paper indicate that Axl expression is responsible for increased resistance to doxorubicin-and etoposide treatment, and this phenomenon was most prominent for the CD44-high cancer stem cell population. We also found a correlation of Axl and ALDH1 expression, and it was previously suggested that stem-like populations with elevated levels of ALDH1 might be involved in doxorubicin and cisplatin resistance. 45 Administration of anti-Axl monoclonal antibodies enhanced the anti-tumor effect of anti-VEGF therapy, the smallmolecule EGFR inhibitor erlotinib and chemotherapy consisting of paclitaxel and carboplatin; 46 however, we suggest that the chemotherapy-protective effect of Axl might be limited to the CSC population. Furthermore, a recent study demonstrated that Axl inhibition in non-small cell lung cancer reversed resistance to erlotinib. 47 In conclusion, we believe that Axl upregulation by CSCs might not only provide them with chemotherapeutic resistance and survival advantage but also facilitate the phenotypic change from stationary to migratory cells in order to establish metastases, as Axl is a major regulator of cell-cell adhesion. Further development of Axl inhibitors for use in clinical trials 48 may provide additional efficacy to existing cancer therapies by targeting CSCs.
